A 10-year-old neutered male Domestic Shorthair presents w...

Hello, thank you for reaching out. This is a classic presentation for feline chronic kidney disease (CKD), and the laboratory values certainly support that diagnosis. Let's systematically approach this cat's IRIS staging.

First, we establish the primary IRIS stage based on the fasting serum creatinine concentration.

Primary IRIS Staging Based on Creatinine

The IRIS (International Renal Interest Society) guidelines for cats are as follows:

* IRIS Stage 1: Creatinine <1.6 mg/dL
* IRIS Stage 2: Creatinine 1.6-2.8 mg/dL
* IRIS Stage 3: Creatinine 2.9-5.0 mg/dL
* IRIS Stage 4: Creatinine >5.0 mg/dL

Your patient's creatinine is 2.8 mg/dL. Based purely on creatinine, this value places the cat at the very upper end of IRIS Stage 2.

Refining Staging with SDMA

Now, we incorporate the SDMA (Symmetric Dimethylarginine) value. SDMA is a valuable biomarker that can detect CKD earlier than creatinine and can also influence the IRIS stage, particularly when creatinine is borderline or lower. The IRIS guidelines state that if both creatinine and SDMA concentrations are increased, the higher IRIS stage based on either parameter should be used for classification.

Let's look at the general correlations between SDMA and IRIS stages:

* SDMA 18-25 µg/dL: Generally correlates with early IRIS Stage 2
* SDMA 26-38 µg/dL: Generally correlates with IRIS Stage 3
* SDMA >38 µg/dL: Generally correlates with IRIS Stage 4

Your patient's SDMA is 28 µg/dL. This value clearly falls into the range typically associated with IRIS Stage 3.

Given that the IRIS guidelines instruct us to use the higher stage based on either parameter when both are elevated, the SDMA of 28 µg/dL effectively "upstages" this cat from a high-end Stage 2 (by creatinine) to IRIS Stage 3. The clinical signs of polyuria, polydipsia, and weight loss, along with a USG of 1.018 (indicating impaired concentrating ability), are all consistent with significant renal dysfunction at this stage. The elevated BUN (65 mg/dL) further supports the uremia associated with Stage 3 CKD.

Role of Blood Pressure and Proteinuria (Sub-staging)

While we have established the primary IRIS stage, the IRIS guidelines also require sub-staging based on blood pressure and proteinuria to provide a more complete picture of the patient's prognosis and to guide specific therapeutic interventions.

Blood Pressure: Systemic hypertension is a common and serious complication of feline CKD. It can lead to target organ damage, particularly to the eyes (retinal detachment, hemorrhage), brain, heart, and further damage to the kidneys. Regular assessment of blood pressure is crucial.

* Normotensive: SBP <150 mmHg
* Borderline Hypertensive: SBP 150-159 mmHg
* Hypertensive: SBP 160-179 mmHg
* Severely Hypertensive: SBP >180 mmHg
If hypertension is identified, it would necessitate specific anti-hypertensive therapy, typically with amlodipine 0.625-1.25 mg PO q24h for cats.

Proteinuria: Persistent proteinuria, assessed by a urine protein:creatinine (UP/C) ratio, is another significant prognostic indicator for CKD progression. Proteinuria suggests glomerular damage and contributes to tubulointerstitial inflammation and fibrosis, accelerating kidney decline.

* Non-proteinuric (NP): UP/C <0.2
* Borderline Proteinuric (BrdP): UP/C 0.2-0.4
* Proteinuric (P): UP/C >0.4
If proteinuria is present, specific interventions such as a renal diet and potentially angiotensin-converting enzyme (ACE) inhibitors (e.g., benazepril 0.5-1.0 mg/kg PO q24h) would be indicated.

Conclusion

Based on the provided information, this 10-year-old DSH cat is accurately staged as IRIS CKD Stage 3.

To complete the staging and guide comprehensive management, I would strongly recommend:

Measuring systemic blood pressure to assess for hypertension.

Performing a urine protein:creatinine (UP/C) ratio on a non-turbid urine sample to assess for proteinuria.

These additional pieces of information are critical for tailoring a precise treatment plan, including dietary recommendations, potential anti-hypertensives, and anti-proteinuric medications, all of which will impact this cat's long-term quality of life and prognosis.